Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
dc.contributor.author | Öhlund, Daniel | |
dc.contributor.author | Handly-Santana, Abram | |
dc.contributor.author | Biffi, Giulia | |
dc.contributor.author | Elyada, Ela | |
dc.contributor.author | Almeida, Ana S. | |
dc.contributor.author | Ponz-Sarvise, Mariano | |
dc.contributor.author | Corbo, Vincenzo | |
dc.contributor.author | Oni, Tobiloba E. | |
dc.contributor.author | Hearn, Stephen A. | |
dc.contributor.author | Lee, Eun Jung | |
dc.contributor.author | Chio, Iok In Christine | |
dc.contributor.author | Hwang, Chang-Il | |
dc.contributor.author | Tiriac, Herve | |
dc.contributor.author | Baker, Lindsey A. | |
dc.contributor.author | Engle, Dannielle D. | |
dc.contributor.author | Feig, Christine | |
dc.contributor.author | Kultti, Anne | |
dc.contributor.author | Egeblad, Mikala | |
dc.contributor.author | Fearon, Douglas T. | |
dc.contributor.author | Crawford, James M. | |
dc.contributor.author | Clevers, Hans | |
dc.contributor.author | Park, Youngkyu | |
dc.contributor.author | Tuveson, David A. | |
dc.contributor.funder | Nancy Gay fellowship | |
dc.contributor.funder | National Cancer Institute | |
dc.contributor.funder | Damon Runyon Cancer Research Foundation | |
dc.contributor.funder | Associazione Italiana per la Ricerca sul Cancro | |
dc.contributor.funder | Ministero della Salute | |
dc.contributor.funder | European Molecular Biology Organization | |
dc.contributor.funder | Weizmann Institute of Science | |
dc.contributor.funder | Human Frontiers Science Program | |
dc.contributor.funder | Cancer Research Foundation in Northern Sweden | |
dc.contributor.funder | Västerbotten Läns Landsting | |
dc.contributor.funder | Svenska Läkaresällskapet | |
dc.contributor.funder | Kempestiftelserna | |
dc.contributor.funder | Vetenskapsrådet | |
dc.contributor.funder | Precision Medicine Research Associates | |
dc.contributor.funder | U.S. Department of Defense | |
dc.contributor.funder | Starr Foundation | |
dc.contributor.funder | KWF Kankerbestrijding | |
dc.contributor.funder | Stand Up To Cancer | |
dc.contributor.funder | National Institutes of Health | |
dc.contributor.funder | Lustgarten Foundation | |
dc.contributor.funder | National Cancer Institute | |
dc.contributor.funder | Cold Spring Harbor | |
dc.date.accessioned | 2018-06-15T11:47:20Z | |
dc.date.available | 2018-06-15T11:47:20Z | |
dc.date.issued | 2017 | |
dc.description.abstract | Pancreatic stellate cells (PSCs) differentiate into cancer-associated fibroblasts (CAFs) that produce desmoplastic stroma, thereby modulating disease progression and therapeutic response in pancreatic ductal adenocarcinoma (PDA). However, it is unknown whether CAFs uniformly carry out these tasks or if subtypes of CAFs with distinct phenotypes in PDA exist. We identified a CAF subpopulation with elevated expression of a-smooth muscle actin (alpha SMA) located immediately adjacent to neoplastic cells in mouse and human PDA tissue. We recapitulated this finding in co-cultures of murine PSCs and PDA organoids, and demonstrated that organoid-activated CAFs produced desmoplastic stroma. The co-cultures showed cooperative interactions and revealed another distinct subpopulation of CAFs, located more distantly from neoplastic cells, which lacked elevated aSMA expression and instead secreted IL6 and additional inflammatory mediators. These findings were corroborated in mouse and human PDA tissue, providing direct evidence for CAF heterogeneity in PDA tumor biology with implications for disease etiology and therapeutic development. | en |
dc.description.sponsorship | Cold Spring Harbor (Cancer Center Support Grant (CCSG); Laboratory Association); National Institutes of Health (5P30CA45508-26; 5P50CA101955-07; 1U10CA180944-02; 5U01CA168409-5; 1R01CA188134; 1R01CA190092-03; R50CA311506-01; CA101955 UAB/UMN SPORE; 5T32CA148056; F32CA192904); Starr Foundation (I7-A718); U.S. Department of Defense(W81XWH-13-PRCRP-IA);Vetenskapsrådet (537-2013-7277); Kempestiftelserna (JCK-1301); Svenska Läkaresällskapet (SLS-326921, SLS-250831, SLS175991, SLS-591551); Västerbotten Läns Landsting (ALFVLL269081, VLL242121, VLL322391, VLL400421, VLL493371, VLL582681); Cancer Research Foundation in Northern Sweden (AMP15-793, LP11-1927); Human Frontiers Science Program (LT000403/2014, LT000195/2015-L, LT000190/2013); Weizmann Institute of Science (Women in Science award); European Molecular Biology Organization (ALTF 1203-2014); Ministero della Salute (FIRB - RBAP10AHJ); Associazione Italiana Ricerca Cancro (18718); Damon Runyon Cancer Research Foundation (DRG-2165-13); National Cancer Institute (1K99CA204725-01A1) | en |
dc.description.status | Peer reviewed | |
dc.description.version | Published Version | en |
dc.format.mimetype | application/pdf | en |
dc.identifier.citation | Öhlund, D., Handly-Santana, A., Biffi, G., Elyada, E., Almeida, A. S., Ponz-Sarvise, M., Corbo, V., Oni, T. E., Hearn, S. A., Lee, E. J., Chio, I. I. C., Hwang, C.-I., Tiriac, H., Baker, L. A., Engle, D. D., Feig, C., Kultti, A., Egeblad, M., Fearon, D. T., Crawford, J. M., Clevers, H., Park, Y. and Tuveson, D. A. (2017) 'Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer', Journal of Experimental Medicine, 214(3), pp. 579-596. doi: 10.1084/jem.20162024 | en |
dc.identifier.doi | 10.1084/jem.20162024 | |
dc.identifier.endpage | 596 | |
dc.identifier.issn | 0022-1007 | |
dc.identifier.issued | 3 | |
dc.identifier.journaltitle | Journal of Experimental Medicine | en |
dc.identifier.startpage | 579 | |
dc.identifier.uri | https://hdl.handle.net/10468/6359 | |
dc.identifier.volume | 214 | |
dc.language.iso | en | en |
dc.publisher | Rockefeller University Press | en |
dc.relation.uri | http://jem.rupress.org/content/214/3/579 | |
dc.rights | © 2017, Öhlund et al. This article is available under a Creative Commons License (Attribution 4.0 International, as described at https://creativecommons.org/licenses/by/4.0/) | en |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
dc.subject | Stellate cells | en |
dc.subject | Ductal adenocarcinoma | en |
dc.subject | Tumor microenvironment | en |
dc.subject | RNA-seq | en |
dc.subject | Stroma | en |
dc.subject | Progression | en |
dc.subject | Interleukin-6 | en |
dc.subject | Gemcitabine | en |
dc.subject | Resistance | en |
dc.subject | Differentiation | en |
dc.title | Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer | en |
dc.type | Article (peer-reviewed) | en |
Files
Original bundle
1 - 3 of 3
Loading...
- Name:
- 579.full.pdf
- Size:
- 3.32 MB
- Format:
- Adobe Portable Document Format
- Description:
- Published Version
Loading...
- Name:
- JEM_20162024_TableS1.xls
- Size:
- 12.05 MB
- Format:
- Microsoft Excel
- Description:
- Table S1
Loading...
- Name:
- JEM_20162024_sm.pdf
- Size:
- 944.81 KB
- Format:
- Adobe Portable Document Format
- Description:
- Supplemental Material